Ranked by engagement
Top topics — this year
Ranked by replies, likes and views over this year, with a bonus for topics that reached a marked solution. Engagement is a proxy for usefulness and a poor one; the documentation commons is the better index of what is settled.
1,076 topics · page 1 of 14
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Are there stupid questions here? A staff answer, at length
Are there stupid questions here? A staff answer, at length I have a specific reason for asking rather than idle curiosity, and the context is below. Question in the title. Context below, and I have tried to…
|
+122 | 153 | 50k | 11mo |
|
A 10 mg vial reconstituted three different ways, compared — the long version
A 10 mg vial reconstituted three different ways, compared — the long version — setting out what I have, and where I think it stops being reliable. Reporting something rather than asking about it, in case the…
|
+146 | 158 | 47k | 9mo |
|
When a preprint is the best available evidence and we say so
When a preprint is the best available evidence and we say so — that is the question, and I have not found it answered plainly anywhere I have looked. I have seen SURPASS-2 ( N Engl J Med , 2021) cited in…
|
+148 | 160 | 31k | 11mo |
|
Domestic fridge temperature mapping: a cheap experiment — what changed since
Domestic fridge temperature mapping: a cheap experiment — what changed since — setting out what I have, and where I think it stops being reliable. I have read the maintained page on this and I still have a…
|
+145 | 155 | 46k | 12mo |
|
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — setting out what I have, and where I think it stops being reliable. Comparing SURMOUNT-2 ( Lancet , 2023) with STEP 2 ( Lancet ,…
|
+150 | 163 | 22k | 11mo |
|
Second pass at: Metformin co-administration and additive GI effects
On the subject in the title: Second pass at: Metformin co-administration and additive GI effects Working notes rather than a conclusion. I have read the maintained page on this and I still have a gap, so I am…
|
+131 | 142 | 56k | 19d |
|
"Greater than or equal to 99%" as a specification rather than a result
"Greater than or equal to 99%" as a specification rather than a result Writing it up because I had to work it out twice and would rather nobody else did. Working through the identity arithmetic and I would…
|
+132 | 146 | 47k | 5mo |
|
The anatomy of a question that gets answered within an hour — the long version
The anatomy of a question that gets answered within an hour — the long version Writing it up because I had to work it out twice and would rather nobody else did. Question in the title. Context below, and I…
|
+129 | 142 | 49k | 8mo |
|
Price changes over 2025 and 2026, tabulated and dated — does this still hold?
Price changes over 2025 and 2026, tabulated and dated — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Documenting an access outcome, dated,…
|
+147 | 156 | 18k | 3mo |
|
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field — setting out what I have, and where I think it stops being reliable. Comparing LEADER ( N Engl J Med , 2016) with SUSTAIN 6 ( N Engl…
|
+108 | 122 | 52k | 7d |
|
Sleep tracking data and its considerable limitations
Sleep tracking data and its considerable limitations — setting out what I have, and where I think it stops being reliable. Asking about a population rather than about a person. The published trials in this…
|
+109 | 126 | 61k | 9mo |
|
[2026 update] Regional warehouse stock versus direct despatch
Regional warehouse stock versus direct despatch Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the answers here are usually better than anywhere…
|
+135 | 147 | 32k | 2d |
|
Titles that describe the question, not the situation
Titles that describe the question, not the situation — setting out what I have, and where I think it stops being reliable. Question in the title. Context below, and I have tried to include the things people…
|
+139 | 153 | 22k | 8mo |
|
Coming back to: What published stability data actually covers, and what it does not
The question in the title: What published stability data actually covers, and what it does not I will give what I have already checked below so nobody repeats it. Practical question with the units stated,…
|
+136 | 148 | 20k | 10mo |
|
[2026 update] Interpreting a result that disagrees with the supplier's certificate
On the subject in the title: Interpreting a result that disagrees with the supplier's certificate Working notes rather than a conclusion. Structured report rather than an opinion, following the format the…
|
+121 | 128 | 51k | 17h |
|
Second pass at: Why this subcategory is stricter about sourcing than most
Second pass at: Why this subcategory is stricter about sourcing than most — setting out what I have, and where I think it stops being reliable. Comparing LEADER ( N Engl J Med , 2016) with SURMOUNT-4 ( JAMA ,…
|
+120 | 129 | 61k | 11mo |
|
An appeal that succeeded, with the letter structure — the long version
An appeal that succeeded, with the letter structure — the long version — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that…
|
+113 | 136 | 32k | 1mo |
|
Second pass at: A history of disordered eating: proceeding carefully
On the subject in the title: Second pass at: A history of disordered eating: proceeding carefully Working notes rather than a conclusion. General question, not a request for advice about my own care — I know…
|
+125 | 132 | 51k | 10mo |
|
Revisiting: Language barriers in accessing a prescription abroad
Posting this under the heading it deserves: Revisiting: Language barriers in accessing a prescription abroad Everything below is what sits behind that. Documenting an access outcome, dated, because everything…
|
+131 | 148 | 28k | 5mo |
|
Aggregated purity results across four services, with caveats — a second dataset
Aggregated purity results across four services, with caveats — a second dataset — setting out what I have, and where I think it stops being reliable. Working through the identity arithmetic and I would like…
|
+127 | 151 | 42k | 10mo |
|
The headache that turns out to be dehydration
The headache that turns out to be dehydration Writing it up because I had to work it out twice and would rather nobody else did. Maintenance rather than loss, which is the part of this that almost nobody…
|
+143 | 158 | 7.8k | 6mo |
|
Warfarin and altered intake: the monitoring argument — the long version
Posting this under the heading it deserves: Warfarin and altered intake: the monitoring argument — the long version Everything below is what sits behind that. Reporting something rather than asking about it,…
|
+123 | 134 | 40k | 4mo |
|
Asking about a compound your prescriber has not heard of
Asking about a compound your prescriber has not heard of Writing it up because I had to work it out twice and would rather nobody else did. General question, not a request for advice about my own care — I…
|
+137 | 148 | 15k | 11mo |
|
Temperature loggers worth the money — the long version
On the subject in the title: Temperature loggers worth the money — the long version Working notes rather than a conclusion. Reporting something rather than asking about it, in case the pattern is useful to…
|
+110 | 127 | 48k | 6mo |
|
Follow-up: The decimal-point error, and the habit that catches it
On the subject in the title: The decimal-point error, and the habit that catches it Working notes rather than a conclusion. I have read the maintained page on this and I still have a gap, so I am asking…
|
+118 | 131 | 50k | 7mo |
|
What happens after your first post: likes, trust levels, and why none of it matters much — what changed since
The question in the title: What happens after your first post: likes, trust levels, and why none of it matters much — what changed since I will give what I have already checked below so nobody repeats it. I…
|
+105 | 118 | 57k | 9mo |
|
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on
Posting this under the heading it deserves: SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Everything below is what sits behind that. Comparing SURPASS-2 ( N Engl J Med…
|
+122 | 136 | 48k | 9mo |
|
Measurement error in a self-reported exposure
Posting this under the heading it deserves: Measurement error in a self-reported exposure Everything below is what sits behind that. Session topic: SURPASS-2 ( N Engl J Med , 2021). Please read it before…
|
+117 | 129 | 45k | 5mo |
|
Interpreting a result that disagrees with the supplier's certificate
Interpreting a result that disagrees with the supplier's certificate Writing it up because I had to work it out twice and would rather nobody else did. Structured report rather than an opinion, following the…
|
+129 | 153 | 7.3k | 5mo |
|
What consumer-accessible tests can and cannot determine — a second dataset
What consumer-accessible tests can and cannot determine — a second dataset I have a specific reason for asking rather than idle curiosity, and the context is below. Posting the method first, because I know…
|
+117 | 131 | 45k | 10h |
Sponsored
Janoshik Analytical — independent third-party testingHPLC purity and mass-spectrometric identity on submitted samples, reported with the method stated. The laboratory most often cited in this community’s verification records.Independent testing →
Sponsored
GL Biochem (Shanghai) Ltd. — synthesis, directFounded 1998. ISO 9001 and cGMP certified, over 1,500 staff and 200-plus patents. Custom peptide synthesis and amino acid derivatives, with a batch certificate on every order.Custom synthesis →